Genome structure and transcriptional regulation of human coronavirus NL63

Krzysztof Pyrc1, Maarten F Jebbink1, Ben Berkhout1, Lia van der Hoek1
1Department of Human Retrovirology, University of Amsterdam, College Station, Netherlands

Tóm tắt

Two human coronaviruses are known since the 1960s: HCoV-229E and HCoV-OC43. SARS-CoV was discovered in the early spring of 2003, followed by the identification of HCoV-NL63, the fourth member of the coronaviridae family that infects humans. In this study, we describe the genome structure and the transcription strategy of HCoV-NL63 by experimental analysis of the viral subgenomic mRNAs. The genome of HCoV-NL63 has the following gene order: 1a-1b-S-ORF3-E-M-N. The GC content of the HCoV-NL63 genome is extremely low (34%) compared to other coronaviruses, and we therefore performed additional analysis of the nucleotide composition. Overall, the RNA genome is very low in C and high in U, and this is also reflected in the codon usage. Inspection of the nucleotide composition along the genome indicates that the C-count increases significantly in the last one-third of the genome at the expense of U and G. We document the production of subgenomic (sg) mRNAs coding for the S, ORF3, E, M and N proteins. We did not detect any additional sg mRNA. Furthermore, we sequenced the 5' end of all sg mRNAs, confirming the presence of an identical leader sequence in each sg mRNA. Northern blot analysis indicated that the expression level among the sg mRNAs differs significantly, with the sg mRNA encoding nucleocapsid (N) being the most abundant. The presented data give insight into the viral evolution and mutational patterns in coronaviral genome. Furthermore our data show that HCoV-NL63 employs the discontinuous replication strategy with generation of subgenomic mRNAs during the (-) strand synthesis. Because HCoV-NL63 has a low pathogenicity and is able to grow easily in cell culture, this virus can be a powerful tool to study SARS coronavirus pathogenesis.

Từ khóa


Tài liệu tham khảo

Drosten C, Gunther S, Preiser W, van der Werf S, Brodt HR, Becker S, Rabenau H, Panning M, Kolesnikova L, Fouchier RA, Berger A, Burguiere AM, Cinatl J, Eickmann M, Escriou N, Grywna K, Kramme S, Manuguerra JC, Muller S, Rickerts V, Sturmer M, Vieth S, Klenk HD, Osterhaus AD, Schmitz H, Doerr HW: Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003, 348: 1967-1976. 10.1056/NEJMoa030747

Kuiken T, Fouchier RA, Schutten M, Rimmelzwaan GF, van Amerongen G, van Riel D, Laman JD, de Jong T, van Doornum G, Lim W, Ling AE, Chan PK, Tam JS, Zambon MC, Gopal R, Drosten C, van der Werf S, Escriou N, Manuguerra JC, Stohr K, Peiris JS, Osterhaus AD: Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet 2003, 362: 263-270. 10.1016/S0140-6736(03)13967-0

Gibbs AJ, Gibbs MJ, Armstrong JS: The phylogeny of SARS coronavirus. Arch Virol 2004, 149: 621-624. 10.1007/s00705-003-0244-0

Snijder EJ, Bredenbeek PJ, Dobbe JC, Thiel V, Ziebuhr J, Poon LL, Guan Y, Rozanov M, Spaan WJ, Gorbalenya AE: Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage. J Mol Biol 2003, 331: 991-1004. 10.1016/S0022-2836(03)00865-9

Rota PA, Oberste MS, Monroe SS, Nix WA, Campagnoli R, Icenogle JP, Penaranda S, Bankamp B, Maher K, Chen MH, Tong S, Tamin A, Lowe L, Frace M, DeRisi JL, Chen Q, Wang D, Erdman DD, Peret TC, Burns C, Ksiazek TG, Rollin PE, Sanchez A, Liffick S, Holloway B, Limor J, McCaustland K, Olsen-Rasmussen M, Fouchier R, Gunther S, Osterhaus AD, Drosten C, Pallansch MA, Anderson LJ, Bellini WJ: Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 2003, 300: 1394-1399. 10.1126/science.1085952

van der Hoek L, Pyrc K, Jebbink MF, Vermeulen-Oost W, Berkhout RJ, Wolthers KC, Wertheim-van Dillen PM, Kaandorp J, Spaargaren J, Berkhout B: Identification of a new human coronavirus. Nat Med 2004, 10: 368-373. 10.1038/nm1024

Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Peret T, Emery S, Tong S, Urbani C, Comer JA, Lim W, Rollin PE, Dowell SF, Ling AE, Humphrey CD, Shieh WJ, Guarner J, Paddock CD, Rota P, Fields B, DeRisi J, Yang JY, Cox N, Hughes JM, LeDuc JW, Bellini WJ, Anderson LJ: A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003, 348: 1953-1966. 10.1056/NEJMoa030781

Herold J, Siddell SG: An 'elaborated' pseudoknot is required for high frequency frameshifting during translation of HCV 229E polymerase mRNA. Nucleic Acids Res 1993, 21: 5838-5842.

Giedroc DP, Theimer CA, Nixon PL: Structure, stability and function of RNA pseudoknots involved in stimulating ribosomal frameshifting. J Mol Biol 2000, 298: 167-185. 10.1006/jmbi.2000.3668

Gagneten S, Gout O, Dubois-Dalcq M, Rottier P, Rossen J, Holmes KV: Interaction of mouse hepatitis virus (MHV) spike glycoprotein with receptor glycoprotein MHVR is required for infection with an MHV strain that expresses the hemagglutinin-esterase glycoprotein. J Virol 1995, 69: 889-895.

Zhang X, Hinton DR, Park S, Parra B, Liao CL, Lai MM, Stohlman SA: Expression of hemagglutinin/esterase by a mouse hepatitis virus coronavirus defective-interfering RNA alters viral pathogenesis. Virology 1998, 242: 170-183. 10.1006/viro.1997.8993

de Haan CA, Masters PS, Shen X, Weiss S, Rottier PJ: The group-specific murine coronavirus genes are not essential, but their deletion, by reverse genetics, is attenuating in the natural host. Virology 2002, 296: 177-189. 10.1006/viro.2002.1412

Sawicki SG, Sawicki DL: Coronavirus transcription: subgenomic mouse hepatitis virus replicative intermediates function in RNA synthesis. J Virol 1990, 64: 1050-1056.

Sawicki SG, Sawicki DL: A new model for coronavirus transcription. Adv Exp Med Biol 1998, 440: 215-219.

Spaan W, Delius H, Skinner M, Armstrong J, Rottier P, Smeekens S, van der Zeijst BA, Siddell SG: Coronavirus mRNA synthesis involves fusion of non-contiguous sequences. EMBO J 1983, 2: 1839-1844.

Hofmann MA, Chang RY, Ku S, Brian DA: Leader-mRNA junction sequences are unique for each subgenomic mRNA species in the bovine coronavirus and remain so throughout persistent infection. Virology 1993, 196: 163-171. 10.1006/viro.1993.1464

Konings DA, Bredenbeek PJ, Noten JF, Hogeweg P, Spaan WJ: Differential premature termination of transcription as a proposed mechanism for the regulation of coronavirus gene expression. Nucleic Acids Res 1988, 16: 10849-10860.

Sethna PB, Hung SL, Brian DA: Coronavirus subgenomic minus-strand RNAs and the potential for mRNA replicons. Proc Natl Acad Sci U S A 1989, 86: 5626-5630.

de Haan CA, van Genne L, Stoop JN, Volders H, Rottier PJ: Coronaviruses as vectors: position dependence of foreign gene expression. J Virol 2003, 77: 11312-11323. 10.1128/JVI.77.21.11312-11323.2003

Grigoriev A: Mutational patterns correlate with genome organization in SARS and other coronaviruses. Trends Genet 2004, 20: 131-135. 10.1016/j.tig.2004.01.009

Grigoriev A: Strand-specific compositional asymmetries in double-stranded DNA viruses. Virus Res 1999, 60: 1-19. 10.1016/S0168-1702(98)00139-7

Hiscox JA, Mawditt KL, Cavanagh D, Britton P: Investigation of the control of coronavirus subgenomic mRNA transcription by using T7-generated negative-sense RNA transcripts. J Virol 1995, 69: 6219-6227.

Hacker J, Kaper JB: Pathogenicity islands and the evolution of microbes. Annu Rev Microbiol 2000, 54: 641-679. 10.1146/annurev.micro.54.1.641

Sueoka N: Correlation between Base Composition of Deoxyribonucleic Acid and Amino Acid Composition of Protein. Proc Natl Acad Sci U S A 1961, 47: 1141-1149.

Berkhout B, van Hemert FJ: The unusual nucleotide content of the HIV RNA genome results in a biased amino acid composition of HIV proteins. Nucleic Acids Res 1994, 22: 1705-1711.

van Hemert FJ, Berkhout B: The tendency of lentiviral open reading frames to become A-rich: constraints imposed by viral genome organization and cellular tRNA availability. J Mol Evol 1995, 41: 132-140.

van den Born E, Gultyaev AP, Snijder EJ: Secondary structure and function of the 5'-proximal region of the equine arteritis virus RNA genome. RNA 2004, 10: 424-437. 10.1261/rna.5174804

Nakamura Y, Gojobori T, Ikemura T: Codon usage tabulated from international DNA sequence databases: status for the year 2000. Nucleic Acids Res 2000, 28: 292. 10.1093/nar/28.1.292